Medline Slammed by Earnings; Analysts Cut Targets but Hold Ratings
MDLN enters the post-earnings period carrying a fresh 17% weekly loss and a wave of analyst price-target cuts — a rare moment of unified Street pessimism that still hasn't shaken anyone's positive ratings. The week's…